Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction

International Journal of Clinical Practice

Volumn 60, Issue 10, 2006, Pages 1218-1224

  Sheth, Karen ^a   Wasserman, R L ^b   Lincourt, W R ^c   Locantore, N W ^c   Carranza Rosenzweig, J ^c   Crim, C ^c  

^a Lafayette Allergy and Asthma Clinic   (United States)

^b Pediatric Allergy/Immunology Associates   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Dose counter; Fluticasone propionate; Metered dose inhaler; Salmeterol

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; NEDOCROMIL; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG; THEOPHYLLINE;

ACCURACY; ADOLESCENT; ADULT; ANKLE FRACTURE; ARTICLE; ASTHMA; CELLULITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DOSE REGIMEN; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRY POWDER; EQUIPMENT DESIGN; FEMALE; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; OPEN STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; POWDER INHALER; PRIORITY JOURNAL; SCHOOL CHILD; SORE THROAT; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; MALE; METERED DOSE INHALERS; MIDDLE AGED; PATIENT SATISFACTION; POWDERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 33748579871     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01138.x     Document Type: Article

References (22)

1. Boyd G. The continued need for metered dose inhalers. J Aerosol Med 1995; 8: S9-S12.
2. Rubin BK, Durotoye L. How do patients determine that their metered-dose inhaler is empty ? Chest 2004; 126: 1134-7.
3. Cain WT, Oppenheimer JJ. The misconception of using floating patterns as an accurate means of measuring the contents of metered-dose inhaler devices. Ann Allergy Asthma Immunol 2001; 87: 417-9.
4. Guidance for Industry. Integration of Dose-counting Mechanisms into MDI Drug Products. US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research, Division of Pulmonary and Allergy Drug Products. Rockville, Maryland: Guidance for Industry, 2003.
5. Bergner A, Griesner WA III, Bergner RK. Metered-dose inhalers: The specified number of sprays. JAMA 1993; 269: 1506.
6. United Nations Environmental Programme (Ozone Secretariat). Handbook for the International Treaties for the Protection of the Ozone Layer, 4th edn. Kenya: United Nations Environmental Programme, 1996.
7. Sander N, Fusco-Walker SJ, Harder JM, Chipps BE. Dose counting and the use of pressurized metered-dose inhalers: Running on empty. Ann Allergy Asthma Immunol 2006; 97: 34-8.
8. Ogren RA, Baldwin JL, Simon RA. How patients determine when to replace their metered-dose inhalers. Ann Allergy Asthma Immunol 1995; 75: 485-9.
9. Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 2002; 121: 871-6.
10. Brueckner JW, Marshik P, Sherman J et al. Reliability of the Medtrac MDI Chronolog. J Allergy Clin Immunol 1997; 100: 488-91.
11. Wamboldt FS, Bender BG, O'Connor SL et al. Reliability of the model MC-311 Chronolog. J Allergy Clin Immunol 1999; 104: 53-7.
12. Simmons MS, Nides MA, Kleerup EC et al. Validation of the Doser CT, a new device for monitoring metered-dose inhaler use. J Allergy Clin Immunol 1998; 102: 409-13.
13. Fan VS, Bryson CL, Curtis JL et al. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization. Am J Respir Crit Care Med 2003; 168: 1488-94.
14. Milgrom H, Bender B, Ackerson L et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051-7.
15. Patterson R, Greenberger PA, Patterson DR. Potentially fatal asthma: The problem of noncompliance. Ann Allergy 1991; 67: 138-42.
16. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326: 862-6.
17. ADVAIR DISKUS ® [package insert]. Research Triangle Park, NC: GlaxoSmithKline, 2004.
18. Spector SL, Kinsman R, Mawhinney H et al. Compliance of patients with asthma with an experimental aerosolized medication: Implications for controlled clinical trials. J Allergy Clin Immunol 1986; 77: 65-70.
19. Mawhinney H, Spector SL, Kinsman RA et al. Compliance in clinical trials of two nonbronchodilator antiasthma medications. Ann Allergy 1991; 66: 294-9.
20. Berg J, Dunbar-Jacob J, Rohay JM. Compliance with inhaled medications: the relationship between diary and electronic monitor. Ann Behav Med 1998; 20: 36-8.
21. Bender B, Wamboldt FS, O'Connor SL et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight and Doser CT. Ann Allergy Asthma Immunol 2000; 85: 416-21.
22. Tashkin DP, Rand C, Nides M et.al. A Nebulizer Chronolog to monitor compliance with inhaler use. Am J Med 1991; 91: 33S-36S.